Terns Pharmaceuticals Inc
NASDAQ:TERN

Watchlist Manager
Terns Pharmaceuticals Inc Logo
Terns Pharmaceuticals Inc
NASDAQ:TERN
Watchlist
Price: 6.36 USD 3.41% Market Closed
Market Cap: 540.2m USD
Have any thoughts about
Terns Pharmaceuticals Inc?
Write Note

Intrinsic Value

TERN's intrinsic value estimate is unreliable because it is based only on its DCF value and doesn't use a relative valuation using multiples.

The intrinsic value of one TERN stock under the Base Case scenario is 3.1 USD. Compared to the current market price of 6.36 USD, Terns Pharmaceuticals Inc is Overvalued by 51%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

TERN Intrinsic Value
3.1 USD
Overvaluation 51%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Terns Pharmaceuticals Inc

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Valuation History Unavailable

Historical valuation for TERN cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about TERN?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Qualitative Analysis
Terns Pharmaceuticals Inc
US
Pharmaceuticals
Market Cap
540.1m USD
IPO
Feb 5, 2021
Employees
41
United States of America
Market Cap
540.1m USD
Industry
Pharmaceuticals
IPO
Feb 5, 2021
Loading...
Loading...
Loading...
Loading...
AI Assistant
AI Assistant
Ask me anything about Terns Pharmaceuticals Inc

Provide an overview of the primary business activities
of Terns Pharmaceuticals Inc.

What unique competitive advantages
does Terns Pharmaceuticals Inc hold over its rivals?

What risks and challenges
does Terns Pharmaceuticals Inc face in the near future?

Has there been any significant insider trading activity
in Terns Pharmaceuticals Inc recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Terns Pharmaceuticals Inc.

Provide P/S
for Terns Pharmaceuticals Inc.

Provide P/E
for Terns Pharmaceuticals Inc.

Provide P/OCF
for Terns Pharmaceuticals Inc.

Provide P/FCFE
for Terns Pharmaceuticals Inc.

Provide P/B
for Terns Pharmaceuticals Inc.

Provide EV/S
for Terns Pharmaceuticals Inc.

Provide EV/GP
for Terns Pharmaceuticals Inc.

Provide EV/EBITDA
for Terns Pharmaceuticals Inc.

Provide EV/EBIT
for Terns Pharmaceuticals Inc.

Provide EV/OCF
for Terns Pharmaceuticals Inc.

Provide EV/FCFF
for Terns Pharmaceuticals Inc.

Provide EV/IC
for Terns Pharmaceuticals Inc.

Show me price targets
for Terns Pharmaceuticals Inc made by professional analysts.

What are the Revenue projections
for Terns Pharmaceuticals Inc?

How accurate were the past Revenue estimates
for Terns Pharmaceuticals Inc?

What are the Net Income projections
for Terns Pharmaceuticals Inc?

How accurate were the past Net Income estimates
for Terns Pharmaceuticals Inc?

What are the EPS projections
for Terns Pharmaceuticals Inc?

How accurate were the past EPS estimates
for Terns Pharmaceuticals Inc?

What are the EBIT projections
for Terns Pharmaceuticals Inc?

How accurate were the past EBIT estimates
for Terns Pharmaceuticals Inc?

Compare the revenue forecasts
for Terns Pharmaceuticals Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Terns Pharmaceuticals Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Terns Pharmaceuticals Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Terns Pharmaceuticals Inc compared to its peers.

Compare the P/E ratios
of Terns Pharmaceuticals Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Terns Pharmaceuticals Inc with its peers.

Analyze the financial leverage
of Terns Pharmaceuticals Inc compared to its main competitors.

Show all profitability ratios
for Terns Pharmaceuticals Inc.

Provide ROE
for Terns Pharmaceuticals Inc.

Provide ROA
for Terns Pharmaceuticals Inc.

Provide ROIC
for Terns Pharmaceuticals Inc.

Provide ROCE
for Terns Pharmaceuticals Inc.

Provide Gross Margin
for Terns Pharmaceuticals Inc.

Provide Operating Margin
for Terns Pharmaceuticals Inc.

Provide Net Margin
for Terns Pharmaceuticals Inc.

Provide FCF Margin
for Terns Pharmaceuticals Inc.

Show all solvency ratios
for Terns Pharmaceuticals Inc.

Provide D/E Ratio
for Terns Pharmaceuticals Inc.

Provide D/A Ratio
for Terns Pharmaceuticals Inc.

Provide Interest Coverage Ratio
for Terns Pharmaceuticals Inc.

Provide Altman Z-Score Ratio
for Terns Pharmaceuticals Inc.

Provide Quick Ratio
for Terns Pharmaceuticals Inc.

Provide Current Ratio
for Terns Pharmaceuticals Inc.

Provide Cash Ratio
for Terns Pharmaceuticals Inc.

What is the historical Revenue growth
over the last 5 years for Terns Pharmaceuticals Inc?

What is the historical Net Income growth
over the last 5 years for Terns Pharmaceuticals Inc?

What is the current Free Cash Flow
of Terns Pharmaceuticals Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Terns Pharmaceuticals Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Terns Pharmaceuticals Inc

Current Assets 376.5m
Cash & Short-Term Investments 372.8m
Other Current Assets 3.7m
Non-Current Assets 1.7m
PP&E 1.7m
Other Non-Current Assets 56k
Current Liabilities 11.4m
Accounts Payable 1.8m
Accrued Liabilities 9.1m
Other Current Liabilities 477k
Non-Current Liabilities 2.4m
Other Non-Current Liabilities 2.4m
Efficiency

Earnings Waterfall
Terns Pharmaceuticals Inc

Revenue
0 USD
Operating Expenses
-100m USD
Operating Income
-100m USD
Other Expenses
11.9m USD
Net Income
-88.1m USD

Free Cash Flow Analysis
Terns Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

TERN Profitability Score
Profitability Due Diligence

Terns Pharmaceuticals Inc's profitability score is 19/100. The higher the profitability score, the more profitable the company is.

19/100
Profitability
Score

Terns Pharmaceuticals Inc's profitability score is 19/100. The higher the profitability score, the more profitable the company is.

TERN Solvency Score
Solvency Due Diligence

Terns Pharmaceuticals Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
81/100
Solvency
Score

Terns Pharmaceuticals Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

TERN Price Targets Summary
Terns Pharmaceuticals Inc

Wall Street analysts forecast TERN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TERN is 19.31 USD with a low forecast of 7.58 USD and a high forecast of 31.5 USD.

Lowest
Price Target
7.58 USD
19% Upside
Average
Price Target
19.31 USD
204% Upside
Highest
Price Target
31.5 USD
395% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for TERN?

Click here to dive deeper.

Dividends

Terns Pharmaceuticals Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for TERN is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

TERN Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

See Also

Discover More
What is the Intrinsic Value of one TERN stock?

The intrinsic value of one TERN stock under the Base Case scenario is 3.1 USD.

Is TERN stock undervalued or overvalued?

Compared to the current market price of 6.36 USD, Terns Pharmaceuticals Inc is Overvalued by 51%.

Back to Top